Longin Rudnicki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Longin Rudnicki has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Sołtan
Central Clinical Hospital of the Medical University of Warsaw, Banacha 1A, 02-097 Warsaw, Poland
12 shared publications - Bartosz Gawior
Mazovian Bródno Hospital, ul. Ludwika Kondratowicza 8, 03-242 Warsaw, Poland
12 shared publications - Dominika Kochan-Olszewska
Holycross Cancer Center in Kielce, ul. Artwińskiego 3, 25-734 Kielce, Poland
12 shared publications - Gracjan Koźma
Military Institute of Aviation Medicine, 54/56 Krasińskiego Street, 01-755 Warsaw, Poland
12 shared publications - Jagoda Prządka
Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz, ul. Jagiellońska 15, 85-067 Bydgoszcz, Poland
12 shared publications - Jakub Pawlicki
Specialist Hospital. St. Wojciech based in Gdansk, Aleja Jana Pawła II 50, 80-462 Gdańsk, Poland
12 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
CAUSES OF PERSISTENT AND RECURRENT SYMPTOMS AFTER FIRST-RIB RESECTION FOR NEUROGENIC THORACIC OUTLET SYNDROME: A NARRATIVE REVIEW
Neurogenic thoracic outlet syndrome (NTOS) may persist after surgery or recur after an initial period of improvement. These outcomes are clinically important because reoperation is technically more demanding, the anatomical cause is often uncertain, and symptom relief is less predictable than after primary decompression. This narrative review examines the mechanisms, diagnostic work-up, and treatment of persistent and recurrent symptoms after first-rib resection and related thoracic outlet decompression. A targeted review of clinical series, registry studies, long-term outcome studies, and systematic reviews was performed, with particular emphasis on studies describing reoperative findings and outcomes. The literature consistently identifies several overlapping mechanisms: retained or residual first-rib segments, residual or reattached scalene muscle, perineural fibrosis, unrecognized pectoralis minor syndrome, multilevel compression, mixed neurovascular compression, secondary injury, and an incorrect or incomplete original diagnosis. Importantly, recurrent NTOS may occur even after an anatomically complete primary decompression; in such cases, dense perineural scar tissue encasing the brachial plexus can be the principal operative finding. Dynamic arterial compression may coexist with neurogenic symptoms and should be considered when discoloration, exertional ischemic symptoms, a positional bruit, or marked changes in subclavian artery flow are present. Diagnostic injections add functional information: a positive response to ultrasound-guided botulinum toxin injection of the anterior scalene and pectoralis minor muscles has a high positive predictive value for surgical response, although a negative response does not reliably exclude benefit. Reoperation is most defensible when symptoms, examination, imaging, and injection response converge on a correctable anatomical target. Complete supraclavicular reoperation and isolated reoperative brachial plexus neurolysis can improve disability and symptoms in selected patients, but outcomes remain variable and complications may be underestimated by 30-day reporting. Careful phenotyping, exclusion of mimics, and treatment in experienced multidisciplinary centers are central to avoiding unnecessary repeat surgery and improving long-term results.
- 24 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessCAUSES OF PERSISTENT AND RECURRENT SYMPTOMS AFTER FIRST-RIB RESECTION FOR NEUROGENIC THORACIC OUTLET SYNDROME: A NARRATIVE REVIEW
Neurogenic thoracic outlet syndrome (NTOS) may persist after surgery or recur after an initial period of improvement. These outcomes are clinically important because reoperation is technically more demanding, the anatomical cause is often uncertain, and symptom relief is less predictable than after primary decompression. This narrative review examines the mechanisms, diagnostic work-up, and treatment of persistent and recurrent symptoms after first-rib resection and related thoracic outlet decompression. A targeted review of clinical series, registry studies, long-term outcome studies, and systematic reviews was performed, with particular emphasis on studies describing reoperative findings and outcomes. The literature consistently identifies several overlapping mechanisms: retained or residual first-rib segments, residual or reattached scalene muscle, perineural fibrosis, unrecognized pectoralis minor syndrome, multilevel compression, mixed neurovascular compression, secondary injury, and an incorrect or incomplete original diagnosis. Importantly, recurrent NTOS may occur even after an anatomically complete primary decompression; in such cases, dense perineural scar tissue encasing the brachial plexus can be the principal operative finding. Dynamic arterial compression may coexist with neurogenic symptoms and should be considered when discoloration, exertional ischemic symptoms, a positional bruit, or marked changes in subclavian artery flow are present. Diagnostic injections add functional information: a positive response to ultrasound-guided botulinum toxin injection of the anterior scalene and pectoralis minor muscles has a high positive predictive value for surgical response, although a negative response does not reliably exclude benefit. Reoperation is most defensible when symptoms, examination, imaging, and injection response converge on a correctable anatomical target. Complete supraclavicular reoperation and isolated reoperative brachial plexus neurolysis can improve disability and symptoms in selected patients, but outcomes remain variable and complications may be underestimated by 30-day reporting. Careful phenotyping, exclusion of mimics, and treatment in experienced multidisciplinary centers are central to avoiding unnecessary repeat surgery and improving long-term results.
- Open Access
- 17 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 73, 75015
Dietary Restrictions, Physical Health, and Cardiovascular Risk: Mechanisms, Clinical Evidence, and Safety Considerations
Background. Intermittent fasting (IF) has emerged as a prominent non-pharmacological strategy in lifestyle medicine and sports science, particularly in the context of cardiovascular disease (CVD) prevention and cardiometabolic optimization. Growing interest in IF reflects its potential to target cardiometabolic risk factors through time-dependent metabolic adaptations rather than continuous caloric restriction. Methods. This narrative review synthesizes current evidence derived from basic experimental research, clinical trials, and systematic reviews evaluating the cardiovascular, metabolic, and physical performance effects of intermittent fasting. The analysis focuses on three primary fasting regimens: time-restricted eating (TRE), alternate-day fasting (ADF), and modified fasting regimens (MFR). Results. Evidence demonstrates that IF induces metabolic switching from glucose utilization to fatty acid oxidation and ketone body production. These adaptations correlate with improvements in blood pressure, atherogenic lipid profiles, glucose–insulin homeostasis, and oxidative stress pathways. Mechanistic studies suggest enhanced autophagy, improved mitochondrial biogenesis, and circadian rhythm alignment contribute to cardiometabolic cardioprotection. However, data regarding long-term safety, hard cardiovascular endpoints, and potential risks such as transient energy deficits remain critical areas of ongoing evaluation. Conclusions. Intermittent fasting represents a highly effective lifestyle intervention for enhancing cardiometabolic health and reducing cardiovascular risk. While short- and medium-term outcomes are favorable, structured clinical oversight is necessary to ensure safety and long-term compliance in clinical and active populations.
- 17 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 73, 75015
Open AccessDietary Restrictions, Physical Health, and Cardiovascular Risk: Mechanisms, Clinical Evidence, and Safety Considerations
Background. Intermittent fasting (IF) has emerged as a prominent non-pharmacological strategy in lifestyle medicine and sports science, particularly in the context of cardiovascular disease (CVD) prevention and cardiometabolic optimization. Growing interest in IF reflects its potential to target cardiometabolic risk factors through time-dependent metabolic adaptations rather than continuous caloric restriction. Methods. This narrative review synthesizes current evidence derived from basic experimental research, clinical trials, and systematic reviews evaluating the cardiovascular, metabolic, and physical performance effects of intermittent fasting. The analysis focuses on three primary fasting regimens: time-restricted eating (TRE), alternate-day fasting (ADF), and modified fasting regimens (MFR). Results. Evidence demonstrates that IF induces metabolic switching from glucose utilization to fatty acid oxidation and ketone body production. These adaptations correlate with improvements in blood pressure, atherogenic lipid profiles, glucose–insulin homeostasis, and oxidative stress pathways. Mechanistic studies suggest enhanced autophagy, improved mitochondrial biogenesis, and circadian rhythm alignment contribute to cardiometabolic cardioprotection. However, data regarding long-term safety, hard cardiovascular endpoints, and potential risks such as transient energy deficits remain critical areas of ongoing evaluation. Conclusions. Intermittent fasting represents a highly effective lifestyle intervention for enhancing cardiometabolic health and reducing cardiovascular risk. While short- and medium-term outcomes are favorable, structured clinical oversight is necessary to ensure safety and long-term compliance in clinical and active populations.
- Open Access
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74894
Sleep quantity and quality as potentially modifiable factors associated with musculoskeletal injury risk in athletes: a narrative review
Background. Sleep is increasingly seen as a potentially modifiable factor in athlete health, but its link to injury risk is not well established across ages and sports. Aim. To summarize evidence on sleep quantity and quality as potential risk factors for musculoskeletal injury in athletes and identify areas of consistency and uncertainty. Material and methods. A narrative review was conducted, based on a structured but incompletely documented PubMed search supplemented by Consensus-assisted literature identification and informed by SANRA. Results. In adolescents, cross-sectional and prospective studies, with a broader review of adolescent sleep and injury literature, reported associations between short or poor sleep and injury risk, with some overlap in cohorts and non-athlete populations. In adults, evidence is heterogeneous, and findings from self-reported and actigraphy-based sleep measures have not been uniform; a systematic review did not confirm sleep as an independent risk factor. Sex, sport, and training load may relate to differences in risk, although evidence of effect modification remains unconfirmed. Conclusions. Short sleep, and less consistently poor sleep quality, are associated with injury risk, particularly in adolescents, and may represent potentially modifiable factors; however, causality and preventive efficacy have not been established, and evidence in adults remains inconsistent. Prospective studies using reproducible methods are needed.
- 15 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74894
Open AccessSleep quantity and quality as potentially modifiable factors associated with musculoskeletal injury risk in athletes: a narrative review
Background. Sleep is increasingly seen as a potentially modifiable factor in athlete health, but its link to injury risk is not well established across ages and sports. Aim. To summarize evidence on sleep quantity and quality as potential risk factors for musculoskeletal injury in athletes and identify areas of consistency and uncertainty. Material and methods. A narrative review was conducted, based on a structured but incompletely documented PubMed search supplemented by Consensus-assisted literature identification and informed by SANRA. Results. In adolescents, cross-sectional and prospective studies, with a broader review of adolescent sleep and injury literature, reported associations between short or poor sleep and injury risk, with some overlap in cohorts and non-athlete populations. In adults, evidence is heterogeneous, and findings from self-reported and actigraphy-based sleep measures have not been uniform; a systematic review did not confirm sleep as an independent risk factor. Sex, sport, and training load may relate to differences in risk, although evidence of effect modification remains unconfirmed. Conclusions. Short sleep, and less consistently poor sleep quality, are associated with injury risk, particularly in adolescents, and may represent potentially modifiable factors; however, causality and preventive efficacy have not been established, and evidence in adults remains inconsistent. Prospective studies using reproducible methods are needed.
- Open Access
- 14 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74831
Yerba Mate Consumption and Exercise Performance: Physiological Effects, Potential Benefits and Safety – A Narrative Review
Introduction. Yerba mate, a traditional beverage prepared from the leaves of Ilex paraguariensis, originates from South America but has gained increasing popularity worldwide. It has also attracted considerable interest among physically active individuals due to its high content of methylxanthines, chlorogenic acids, saponins, polyphenols, and other bioactive compounds. Its potential ergogenic and health-promoting properties have made yerba mate an increasingly important subject of research in the field of sports medicine and exercise science. Background. Current evidence suggests that yerba mate exerts pleiotropic health-promoting effects on the human body and may influence exercise performance through multiple physiological mechanisms. Studies indicate that yerba mate consumption may modulate glucose homeostasis, lipid metabolism, and cellular metabolism, while also exerting stimulatory effects and enhancing antioxidant capacity. However, the available evidence remains heterogeneous, and the assessment of yerba mate effects requires careful critical evaluation. Aim: This narrative review aims to summarize and discuss the current evidence regarding the physiological effects of yerba mate consumption and its potential benefits for exercise performance. In addition, this review synthesizes the available evidence on the safety profile of yerba mate and the potential risks associated with its consumption. Conclusions. Yerba mate appears to be a promising natural supplement with potential ergogenic and health-promoting benefits. Nevertheless, the current evidence remains limited. Further studies are required to confirm its efficacy and clarify the underlying physiological mechanisms.
- 14 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 72, 74831
Open AccessYerba Mate Consumption and Exercise Performance: Physiological Effects, Potential Benefits and Safety – A Narrative Review
Introduction. Yerba mate, a traditional beverage prepared from the leaves of Ilex paraguariensis, originates from South America but has gained increasing popularity worldwide. It has also attracted considerable interest among physically active individuals due to its high content of methylxanthines, chlorogenic acids, saponins, polyphenols, and other bioactive compounds. Its potential ergogenic and health-promoting properties have made yerba mate an increasingly important subject of research in the field of sports medicine and exercise science. Background. Current evidence suggests that yerba mate exerts pleiotropic health-promoting effects on the human body and may influence exercise performance through multiple physiological mechanisms. Studies indicate that yerba mate consumption may modulate glucose homeostasis, lipid metabolism, and cellular metabolism, while also exerting stimulatory effects and enhancing antioxidant capacity. However, the available evidence remains heterogeneous, and the assessment of yerba mate effects requires careful critical evaluation. Aim: This narrative review aims to summarize and discuss the current evidence regarding the physiological effects of yerba mate consumption and its potential benefits for exercise performance. In addition, this review synthesizes the available evidence on the safety profile of yerba mate and the potential risks associated with its consumption. Conclusions. Yerba mate appears to be a promising natural supplement with potential ergogenic and health-promoting benefits. Nevertheless, the current evidence remains limited. Further studies are required to confirm its efficacy and clarify the underlying physiological mechanisms.
- Open Access
- 13 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 71, 74782
Health Consequences of Eating Disorders in Athletes: Underlying Mechanisms and the Role of Relative Energy Deficiency in Sport (RED-S) - A Narrative Review.
Background: Eating disorder is a common mental health condition, where one uses the control of food to cope with overwhelming situations and feelings. Unhealthy habits include eating too little, too much or worrying about the amount of food consumed [1]. Aim: The aim of this study is to discuss the prevalence, manifestations and consequences of eating disorders among athletes. Methods: A focused literature review was conducted using the PubMed database. The search strategy included the following terms: “eating disorder sport athletes”, “eating disorders”, “disordered eating”, “athletes”, “sports”, “energy availability”, “RED-S”, and “female athlete triad”. Relevant studies concerning the physiological, psychological, and performance-related consequences of eating disorders in athletic populations were analyzed. Results: The reviewed literature indicates that eating disorders and disordered eating behaviors are particularly common in sports emphasizing leanness, endurance, or aesthetic appearance. Low energy availability and RED-S were associated with menstrual dysfunction, decreased bone mineral density, increased injury risk, impaired recovery, and reduced athletic performance. Psychological consequences included anxiety, depression, body dissatisfaction, and maladaptive personality traits. These factors collectively contribute to impaired athletic performance and disrupted training continuity. Conclusions: Eating disorders among athletes represent a complex health concern associated with substantial physiological, psychological, and performance-related consequences. Relative energy deficiency appears to be a central underlying mechanism linking many of these effects. Early identification and multidisciplinary management are essential to prevent long-term health complications and performance decline. Future research should focus on standardized assessment methods and improved screening strategies to better address the issue in athletic populations.
- 13 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 71, 74782
Open AccessHealth Consequences of Eating Disorders in Athletes: Underlying Mechanisms and the Role of Relative Energy Deficiency in Sport (RED-S) - A Narrative Review.
Background: Eating disorder is a common mental health condition, where one uses the control of food to cope with overwhelming situations and feelings. Unhealthy habits include eating too little, too much or worrying about the amount of food consumed [1]. Aim: The aim of this study is to discuss the prevalence, manifestations and consequences of eating disorders among athletes. Methods: A focused literature review was conducted using the PubMed database. The search strategy included the following terms: “eating disorder sport athletes”, “eating disorders”, “disordered eating”, “athletes”, “sports”, “energy availability”, “RED-S”, and “female athlete triad”. Relevant studies concerning the physiological, psychological, and performance-related consequences of eating disorders in athletic populations were analyzed. Results: The reviewed literature indicates that eating disorders and disordered eating behaviors are particularly common in sports emphasizing leanness, endurance, or aesthetic appearance. Low energy availability and RED-S were associated with menstrual dysfunction, decreased bone mineral density, increased injury risk, impaired recovery, and reduced athletic performance. Psychological consequences included anxiety, depression, body dissatisfaction, and maladaptive personality traits. These factors collectively contribute to impaired athletic performance and disrupted training continuity. Conclusions: Eating disorders among athletes represent a complex health concern associated with substantial physiological, psychological, and performance-related consequences. Relative energy deficiency appears to be a central underlying mechanism linking many of these effects. Early identification and multidisciplinary management are essential to prevent long-term health complications and performance decline. Future research should focus on standardized assessment methods and improved screening strategies to better address the issue in athletic populations.
- Open Access
- 13 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 71, 74865
Return to Sport After Isolated Meniscal Repair: From Time-Based Protocols to Criteria-Based Clearance. A Narrative Review
Background: Meniscal repair preserves meniscal tissue and may reduce the adverse long-term consequences associated with partial meniscectomy. However, rehabilitation protocols and return-to-sport criteria remain inconsistent, and time since surgery is still often the main factor guiding progression. Aim: To present current evidence on rehabilitation and return to sport after isolated meniscal repair, focusing on return rates and timing, functional criteria, tear- and repair-related factors and return to the preinjury level of sport. Methods: A narrative review was conducted using PubMed/MEDLINE and Google Scholar and supplemented by screening reference lists. Thirty publications were included, with priority given to studies of isolated meniscal repair in athletes and physically active patients. Results: Return-to-play rates ranged from 71.2% to 100%, with time to RTP ranging from 3.3 to 10 months. Return to the same or a higher level of activity was reported in only three studies and ranged from 53.9% to 92.6%. Current evidence supports combining a minimum period needed for biological healing with assessment of pain, effusion, range of motion, muscle strength, neuromuscular control and load tolerance. Stable vertical longitudinal tears may allow faster progression, whereas radial, root, complex and horizontal tears usually require a more restrictive rehabilitation approach. Functional testing may identify persistent deficits, but validated cut-off values specific to isolated meniscal repair are lacking. Return to sport does not necessarily mean return to the preinjury level of sport or full sports performance. Conclusions: Return to sport should be gradual and individualised, based on healing time and clinical, functional and sport-specific criteria. No universal, validated return-to-sport algorithm is currently available. Prospective studies are needed to standardise endpoint definitions and validate progression criteria.
- 13 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 71, 74865
Open AccessReturn to Sport After Isolated Meniscal Repair: From Time-Based Protocols to Criteria-Based Clearance. A Narrative Review
Background: Meniscal repair preserves meniscal tissue and may reduce the adverse long-term consequences associated with partial meniscectomy. However, rehabilitation protocols and return-to-sport criteria remain inconsistent, and time since surgery is still often the main factor guiding progression. Aim: To present current evidence on rehabilitation and return to sport after isolated meniscal repair, focusing on return rates and timing, functional criteria, tear- and repair-related factors and return to the preinjury level of sport. Methods: A narrative review was conducted using PubMed/MEDLINE and Google Scholar and supplemented by screening reference lists. Thirty publications were included, with priority given to studies of isolated meniscal repair in athletes and physically active patients. Results: Return-to-play rates ranged from 71.2% to 100%, with time to RTP ranging from 3.3 to 10 months. Return to the same or a higher level of activity was reported in only three studies and ranged from 53.9% to 92.6%. Current evidence supports combining a minimum period needed for biological healing with assessment of pain, effusion, range of motion, muscle strength, neuromuscular control and load tolerance. Stable vertical longitudinal tears may allow faster progression, whereas radial, root, complex and horizontal tears usually require a more restrictive rehabilitation approach. Functional testing may identify persistent deficits, but validated cut-off values specific to isolated meniscal repair are lacking. Return to sport does not necessarily mean return to the preinjury level of sport or full sports performance. Conclusions: Return to sport should be gradual and individualised, based on healing time and clinical, functional and sport-specific criteria. No universal, validated return-to-sport algorithm is currently available. Prospective studies are needed to standardise endpoint definitions and validate progression criteria.
- Open Access
- 13 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 71, 74956
Tirzepatide in Sport after Inclusion in the WADA Monitoring Program: An Updated Narrative Review of Body Composition, Muscle Preservation and Potential Performance Implications
Background: Tirzepatide, as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has become one of the most effective pharmacological therapies used to treat obesity and metabolic disorders. Growing interest in its potential use among physically active individuals and the inclusion of tirzepatide markers in the World Anti-Doping Agency’s (WADA) monitoring program for 2026 highlight the need to reassess the significance of this substance in sports. Aim: The aim of this study was to update the available data on tirzepatide in the context of sports. Material and methods: A narrative review of the current literature on tirzepatide, incretin receptor agonists and their use in the context of sports was conducted. The analysis included clinical trials, systematic reviews, publications on body composition, metabolism, and exercise adaptation, as well as WADA regulatory documents. Results: Tirzepatide effectively reduces body weight and improves metabolic parameters. However, available evidence mainly concerns individuals with obesity or type 2 diabetes, rather than athletes. Changes in lean body mass during therapy may be relevant for physically active individuals, especially in sports requiring high strength and power. Although weight reduction could be beneficial in weight-class sports. Further studies are needed to assess the long-term impact of tirzepatide on athletic performance and to address the ethical issues associated with its use. Conclusions: Tirzepatide currently has no proven effect on enhancing athletic performance. However, its impact on body weight and body composition may be important for athletes. The inclusion of tirzepatide in WADA’s monitoring program highlights the need for further research into its potential misuse, its effects on muscle, and the long-term consequences of its utilization in the athletic population.
- 13 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 71, 74956
Open AccessTirzepatide in Sport after Inclusion in the WADA Monitoring Program: An Updated Narrative Review of Body Composition, Muscle Preservation and Potential Performance Implications
Background: Tirzepatide, as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has become one of the most effective pharmacological therapies used to treat obesity and metabolic disorders. Growing interest in its potential use among physically active individuals and the inclusion of tirzepatide markers in the World Anti-Doping Agency’s (WADA) monitoring program for 2026 highlight the need to reassess the significance of this substance in sports. Aim: The aim of this study was to update the available data on tirzepatide in the context of sports. Material and methods: A narrative review of the current literature on tirzepatide, incretin receptor agonists and their use in the context of sports was conducted. The analysis included clinical trials, systematic reviews, publications on body composition, metabolism, and exercise adaptation, as well as WADA regulatory documents. Results: Tirzepatide effectively reduces body weight and improves metabolic parameters. However, available evidence mainly concerns individuals with obesity or type 2 diabetes, rather than athletes. Changes in lean body mass during therapy may be relevant for physically active individuals, especially in sports requiring high strength and power. Although weight reduction could be beneficial in weight-class sports. Further studies are needed to assess the long-term impact of tirzepatide on athletic performance and to address the ethical issues associated with its use. Conclusions: Tirzepatide currently has no proven effect on enhancing athletic performance. However, its impact on body weight and body composition may be important for athletes. The inclusion of tirzepatide in WADA’s monitoring program highlights the need for further research into its potential misuse, its effects on muscle, and the long-term consequences of its utilization in the athletic population.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
THE ROLE OF MOBILE HEALTH APPLICATIONS IN CHRONIC DISEASE MANAGEMENT: CURRENT EVIDENCE ON DIABETES, HYPERTENSION, OBESITY, AND REMOTE PATIENT MONITORING- NARRATIVE REVIEW
Background Chronic non-communicable diseases (NCDs), including diabetes mellitus, hypertension, and obesity, remain the leading causes of morbidity, mortality, and healthcare expenditure worldwide [1]. Effective management of these conditions requires continuous monitoring, long-term adherence to treatment, and sustained lifestyle modification. The rapid development of mobile health (mHealth) technologies has created new opportunities to support chronic disease management through smartphone applications, wearable devices, remote patient monitoring (RPM), and artificial intelligence (AI) [52-55]. Objective This review aimed to critically evaluate current evidence regarding the effectiveness of mobile health applications in diabetes mellitus, hypertension, and obesity, with particular emphasis on wearable technologies, remote patient monitoring, and artificial intelligence. Methods A narrative literature review was performed using PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar. Systematic reviews, meta-analyses, randomized controlled trials, observational studies, and international guidelines published between 2018 and 2026 were included. Results Current evidence indicates that mobile health technologies improve glycaemic control, blood pressure management, body weight reduction, medication adherence, patient engagement, and lifestyle modification [7–18,29–39,46–51]. Conclusions Mobile health technologies represent valuable tools facilitating long-term chronic disease management and preventive healthcare. Upcoming research should focus on implementation strategies, lasting effectiveness, interoperability, and safe embedding of artificial intelligence into routine clinical practice [46–58].
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessTHE ROLE OF MOBILE HEALTH APPLICATIONS IN CHRONIC DISEASE MANAGEMENT: CURRENT EVIDENCE ON DIABETES, HYPERTENSION, OBESITY, AND REMOTE PATIENT MONITORING- NARRATIVE REVIEW
Background Chronic non-communicable diseases (NCDs), including diabetes mellitus, hypertension, and obesity, remain the leading causes of morbidity, mortality, and healthcare expenditure worldwide [1]. Effective management of these conditions requires continuous monitoring, long-term adherence to treatment, and sustained lifestyle modification. The rapid development of mobile health (mHealth) technologies has created new opportunities to support chronic disease management through smartphone applications, wearable devices, remote patient monitoring (RPM), and artificial intelligence (AI) [52-55]. Objective This review aimed to critically evaluate current evidence regarding the effectiveness of mobile health applications in diabetes mellitus, hypertension, and obesity, with particular emphasis on wearable technologies, remote patient monitoring, and artificial intelligence. Methods A narrative literature review was performed using PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar. Systematic reviews, meta-analyses, randomized controlled trials, observational studies, and international guidelines published between 2018 and 2026 were included. Results Current evidence indicates that mobile health technologies improve glycaemic control, blood pressure management, body weight reduction, medication adherence, patient engagement, and lifestyle modification [7–18,29–39,46–51]. Conclusions Mobile health technologies represent valuable tools facilitating long-term chronic disease management and preventive healthcare. Upcoming research should focus on implementation strategies, lasting effectiveness, interoperability, and safe embedding of artificial intelligence into routine clinical practice [46–58].
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
PHYSICAL ACTIVITY AS A NON-PHARMACOLOGICAL INTERVENTION FOR DEPRESSIVE SYMPTOMS IN OLDER ADULTS — A NARRATIVE REVIEW
Background. Depression is a common mental health disorder among older adults and is associated with impaired quality of life, functional decline, and increased morbidity. Physical activity has emerged as a promising non-pharmacological intervention; however, uncertainty remains regarding the optimal exercise prescription and the comparative effectiveness of exercise modalities. Aim. To critically evaluate the literature regarding physical activity as a non-pharmacological intervention for depressive symptoms in older adults, with emphasis on exercise modality, exercise dose, intervention duration, long-term outcomes, and methodological limitations. Material and methods. A narrative literature review was conducted using PubMed and Google Scholar. Priority was given to systematic reviews, meta-analyses, network meta-analyses, and randomised controlled trials investigating the effects of physical activity and structured exercise on depressive symptoms in older adults. Results. The accumulated evidence indicates that structured exercise reduces depressive symptoms in older adults, while habitual physical activity is associated with a lower risk of developing depressive symptoms. Although aerobic, resistance, mind–body, walking, neuromotor, and multicomponent exercise have all demonstrated beneficial effects, no single exercise modality has shown consistent superiority among studies. Exercise dose, programme duration, and adherence may influence treatment outcomes, but the optimal exercise prescription remains uncertain because of substantial methodological heterogeneity. Conclusions. Structured exercise is an effective non-pharmacological intervention for reducing depressive symptoms in older adults and should be considered as part of comprehensive depression management. Exercise programmes should be individualised, while further high-quality studies are needed to optimise exercise recommendations and strengthen the evidence base for clinical practice.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessPHYSICAL ACTIVITY AS A NON-PHARMACOLOGICAL INTERVENTION FOR DEPRESSIVE SYMPTOMS IN OLDER ADULTS — A NARRATIVE REVIEW
Background. Depression is a common mental health disorder among older adults and is associated with impaired quality of life, functional decline, and increased morbidity. Physical activity has emerged as a promising non-pharmacological intervention; however, uncertainty remains regarding the optimal exercise prescription and the comparative effectiveness of exercise modalities. Aim. To critically evaluate the literature regarding physical activity as a non-pharmacological intervention for depressive symptoms in older adults, with emphasis on exercise modality, exercise dose, intervention duration, long-term outcomes, and methodological limitations. Material and methods. A narrative literature review was conducted using PubMed and Google Scholar. Priority was given to systematic reviews, meta-analyses, network meta-analyses, and randomised controlled trials investigating the effects of physical activity and structured exercise on depressive symptoms in older adults. Results. The accumulated evidence indicates that structured exercise reduces depressive symptoms in older adults, while habitual physical activity is associated with a lower risk of developing depressive symptoms. Although aerobic, resistance, mind–body, walking, neuromotor, and multicomponent exercise have all demonstrated beneficial effects, no single exercise modality has shown consistent superiority among studies. Exercise dose, programme duration, and adherence may influence treatment outcomes, but the optimal exercise prescription remains uncertain because of substantial methodological heterogeneity. Conclusions. Structured exercise is an effective non-pharmacological intervention for reducing depressive symptoms in older adults and should be considered as part of comprehensive depression management. Exercise programmes should be individualised, while further high-quality studies are needed to optimise exercise recommendations and strengthen the evidence base for clinical practice.
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
EFFECTS OF KETAMINE AND ESKETAMINE ON SUICIDAL IDEATION WITHIN THE FIRST 24 HOURS IN ADULTS WITH DEPRESSIVE DISORDERS: VARIABILITY IN CLINICAL FINDINGS AND INTERPRETATIVE CHALLENGES - A NARRATIVE REVIEW
Background: Ketamine and esketamine have been studied as rapid-acting interventions in adults with depressive disorders and suicidal ideation, but findings vary across populations, settings, comparators, routes, and outcome measures. Aim: To examine their effects on suicidal ideation within the first 24 hours and to identify factors contributing to variability across studies. Methods: This narrative review used a structured PubMed and Scopus search for English-language studies published from January 2000 through April 30, 2026. Clinical trials and relevant secondary studies were considered. No formal risk-of-bias assessment or quantitative synthesis was performed. Results: Intravenous ketamine studies reported rapid reductions in suicidal ideation, although findings were inconsistent. One midazolam-controlled trial showed a 4.96-point greater reduction in the Scale for Suicide Ideation score at 24 hours, whereas another found no significant difference in the primary Beck Scale for Suicide Ideation outcome. Intranasal esketamine added to intensive standard-of-care treatment improved depressive symptoms at 24 hours, but clinician-rated suicidality did not differ significantly between groups in either ASPIRE trial. Conclusions: Intravenous ketamine may rapidly reduce suicidal ideation in selected adults. Intranasal esketamine has shown clearer early effects on depressive symptoms than on suicidality-specific outcomes. Standardized measures and longer follow-up are needed.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessEFFECTS OF KETAMINE AND ESKETAMINE ON SUICIDAL IDEATION WITHIN THE FIRST 24 HOURS IN ADULTS WITH DEPRESSIVE DISORDERS: VARIABILITY IN CLINICAL FINDINGS AND INTERPRETATIVE CHALLENGES - A NARRATIVE REVIEW
Background: Ketamine and esketamine have been studied as rapid-acting interventions in adults with depressive disorders and suicidal ideation, but findings vary across populations, settings, comparators, routes, and outcome measures. Aim: To examine their effects on suicidal ideation within the first 24 hours and to identify factors contributing to variability across studies. Methods: This narrative review used a structured PubMed and Scopus search for English-language studies published from January 2000 through April 30, 2026. Clinical trials and relevant secondary studies were considered. No formal risk-of-bias assessment or quantitative synthesis was performed. Results: Intravenous ketamine studies reported rapid reductions in suicidal ideation, although findings were inconsistent. One midazolam-controlled trial showed a 4.96-point greater reduction in the Scale for Suicide Ideation score at 24 hours, whereas another found no significant difference in the primary Beck Scale for Suicide Ideation outcome. Intranasal esketamine added to intensive standard-of-care treatment improved depressive symptoms at 24 hours, but clinician-rated suicidality did not differ significantly between groups in either ASPIRE trial. Conclusions: Intravenous ketamine may rapidly reduce suicidal ideation in selected adults. Intranasal esketamine has shown clearer early effects on depressive symptoms than on suicidality-specific outcomes. Standardized measures and longer follow-up are needed.